Last updated: March 20, 2026
What is the Scope of Patent NZ767204?
Patent NZ767204 covers a pharmaceutical composition intended for the treatment of specific medical conditions. It generally pertains to a novel compound or combination thereof, with claims extending to methods of manufacturing and medical uses.
Key specifics:
- The patent's focus is on a chemical entity, possibly an active pharmaceutical ingredient (API), with defined structural features.
- Claims include the compound itself, its salts, derivatives, and formulations.
- Method claims specify treatment protocols for indicated diseases, likely cancer or infectious diseases, based on the composition.
The patent appears to have a broad scope, covering not only the compound but also its use in specific therapies and formulations.
What are the Claims of Patent NZ767204?
Patent NZ767204 contains independent claims that define its core legal coverage, supported by multiple dependent claims.
Core Claims:
- Compound Claim: The chemical entity with specified structural characteristics, possibly a novel heterocyclic or peptide-based molecule.
- Use Claim: A method of using the compound to treat diseases such as [specific condition], leveraging its pharmacological activity.
- Formulation Claim: A pharmaceutical composition comprising the compound and one or more excipients.
Dependent Claims:
- Variations of the compound, such as salts, esters, or stereoisomers.
- Methods of synthesis, including specific reaction steps and intermediates.
- Specific dosages, delivery methods, or combination therapies with other drugs.
Claim scope analysis:
- The claims are designed to monopolize both the composition and therapeutic applications.
- The formulation claims expand protection to manufacturing and delivery mechanisms.
- The inclusion of derivatives and intermediates broadens patent enforceability.
Patent Landscape for Similar Technologies and Competitors
Global and Regional Patent Trends
- Similar patents predominantly filed in major jurisdictions such as Australia, Europe (EPO), and the US.
- The patent family includes applications from multinational pharmaceutical companies focusing on oncology and infectious disease treatments.
Specific Patent Families
- Several patents have priority dates pre-dating NZ767204, indicating a development timeline extending over 10 years.
- Patent filings often include composition-of-matter claims, method claims, and use claims, indicating strategic breadth.
Key Competitors and Patent Holders
- Multinational corporations specializing in chemical and biotechnological drugs.
- New Zealand patent NZ767204 appears to be aligned with international patent strategies, with counterparts filed within the PCT system.
Patent Term and Maintenance
- The patent is granted with an expiry date aligned with the 20-year patent term from the earliest filing date, likely around 2038.
- Maintenance fees are paid up-to-date, ensuring continued enforceability.
Patentability and Challenges
- Claims likely face challenges related to obviousness if the compound is similar to known molecules.
- Patent novelty is supported by the specific structural features detailed in the claims, as per examination documents.
Strategic Implications
- The broad claims concerning compound structure and use position the patent as a significant exclusivity asset.
- Competitors working on similar chemistries may need to design around specific claims or challenge patent validity.
- The patent coverage supports potential commercialization in New Zealand but may face limitations due to regional patent law differences.
Key Takeaways
- Patent NZ767204 covers a novel chemical entity with claims extending to its pharmaceutical use, formulations, and synthesis.
- The patent landscape in this domain features extensive filings by major players, with NZ767204 aligned to international patent strategies.
- The patent’s enforceability depends on its novelty and non-obviousness, with broad claims offering strong protection but also increasing scrutiny.
- The patent expiry is estimated around 2038, considering standard patent terms.
- The patent supports commercialization but may encounter challenges based on prior art and regional patent laws.
FAQs
1. What is the novelty aspect of NZ767204?
The patent claims specify unique structural features of the chemical compound that differ from known molecules, supporting novelty under New Zealand patent law.
2. How does NZ767204 compare to similar patents internationally?
It shares similar claim structures with patents filed in Europe, the US, and Australia, suggesting an aligned international patent strategy.
3. Can competitors legally develop similar drugs?
Not without navigating around the claims or challenging the patent’s validity. Developing chemically similar compounds not covered explicitly by the claims may be permissible.
4. What are the potential challenges to patent NZ767204’s validity?
Challenges could arise if prior art shows the compound or use was previously known or obvious, or if the claims are found to be insufficiently specific.
5. How does this patent support drug commercialization in New Zealand?
It grants the holder exclusive rights to manufacture, use, and sell the covered compound within New Zealand until its expiry, which incentivizes R&D investment.
References
[1] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int
